| Title : Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical beta-Blockers - Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| Author(s) : Baker JG , Fromont C , Bruder M , Thompson KSJ , Kellam B , Hill SJ , Gardiner SM , Fischer PM |
| Ref : ACS Pharmacol Transl Sci , 3 :737 , 2020 |
| Abstract : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| ESTHER : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| PubMedSearch : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| PubMedID: 32832874 |